Status:
RECRUITING
Association of Middle Molecules Clearance With HDF Volume
Lead Sponsor:
East and North Hertfordshire NHS Trust
Conditions:
End Stage Renal Disease
Eligibility:
All Genders
18+ years
Brief Summary
HDF is a dialysis technique which involves diffusion and convection. HDF with high convection volume has consistently shown to improve survival in dialysis patients in number of robust RCTs. The preci...
Detailed Description
People with severe kidney failure need treatment by dialysis or transplantation to stay alive. In the UK there are 25,000 people receiving treatment with haemodialysis (HD). Conventional haemodialysis...
Eligibility Criteria
Inclusion
- Age 18 years or above.
- Ability to give informed consent.
- End stage renal failure treated by dialysis for at least 3 months.
- Established on hemodiafiltration for \>4 weeks.
- Prognosis more than 6 months as assessed by PI
Exclusion
- Age less than 18 years.
- Inability to give informed consent.
- Prognosis less than 6 months as assessed by PI
Key Trial Info
Start Date :
January 19 2024
Trial Type :
OBSERVATIONAL
Allocation :
ESTIMATED
End Date :
July 1 2025
Estimated Enrollment :
400 Patients enrolled
Trial Details
Trial ID
NCT06515899
Start Date
January 19 2024
End Date
July 1 2025
Last Update
July 23 2024
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
East and North Hertfordshire NHS Trust
Stevenage, Hertfordshire, United Kingdom, SG1 4AB